Banned or restricted herbal ingredients for medicinal use

AI Summary

This guidance issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) details compliance requirements for manufacturers, wholesalers, and retailers of herbal products. While the document does not reference a specific company or individual inspection dates, it establishes a universal regulatory standard for the industry. The primary focus is the prevention of public health risks associated with the use of banned or improperly regulated substances in herbal medicines. Under the framework of the Human Medicines Regulations (2012), businesses are legally obligated to ensure that their product formulations do not contain prohibited ingredients and that any restricted substances are used strictly within defined legal parameters. Because regulatory restrictions are subject to frequent updates and certain ingredients may carry multiple sets of limitations, the MHRA requires companies to conduct rigorous verification of their ingredient lists. The mandatory action for all stakeholders is to confirm the legality of every component in their products before applying for a traditional herbal registration. Failure to perform this due diligence ensures that products remain compliant with the law and eligible for market access to the market.